Related references
Note: Only part of the references are listed.Recent Advances in Drug-Antibody Ratio Determination of Antibody-Drug Conjugates
Yutaka Matsuda et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2021)
An overview of process development for antibody-drug conjugates produced by chemical conjugation technology
Yutaka Matsuda et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Washing with alkaline solutions in protein A purification improves physicochemical properties of monoclonal antibodies
Yuichi Imura et al.
SCIENTIFIC REPORTS (2021)
Development of a Single-Step Antibody-Drug Conjugate Purification Process with Membrane Chromatography
Juan Carlos Cordova et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Chromatographic analysis of site-specific antibody-drug conjugates produced by AJICAP first-generation technology using a recombinant FcγIIIa receptor-ligand affinity column
Yutaka Matsuda et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)
Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches
Julien Camperi et al.
ANALYST (2021)
FcγRIIIa chromatography to enrich a-fucosylated glycoforms and assess the potency of glycoengineered therapeutic antibodies
Anne Freimoser-Grundschober et al.
JOURNAL OF CHROMATOGRAPHY A (2020)
Clearance of solvents and small molecule impurities in antibody drug conjugates via ultrafiltration and diafiltration operation
Travis J. Gates et al.
BIOTECHNOLOGY PROGRESS (2020)
Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels
Jay Jones et al.
MABS (2020)
Comprehensive online multicolumn two-dimensional liquid chromatography-diode array detection-mass spectrometry workflow as a framework for chromatographic screening and analysis of new drug substances
Chad J. Pickens et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2020)
Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies
Srikanth Kotapati et al.
ANALYTICAL CHEMISTRY (2020)
Antibody–Drug Conjugate Payloads; Study of Auristatin Derivatives
Michinori Akaiwa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2020)
Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation
Yutaka Matsuda et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations
Hyunbo Shim
BIOMOLECULES (2020)
Recent progress in transglutaminase-mediated assembly of antibody-drug conjugates
Hendrik Schneider et al.
ANALYTICAL BIOCHEMISTRY (2020)
Advances in engineering local drug delivery systems for cancer immunotherapy
Peter Abdou et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Evaluation of hydrophobic-interaction chromatography resins for purification of antibody-drug conjugates using a mimetic model with adjustable hydrophobicity
Egbert Mueller et al.
JOURNAL OF SEPARATION SCIENCE (2020)
Synthesis and Biological Evaluation of Antibody Drug Conjugates Based on an Antibody Expression System: Conamax
Zhala Tawfiq et al.
ACS OMEGA (2020)
Insight into Temperature Dependency and Design of Experiments towards Process Development for Cysteine-Based Antibody-Drug Conjugates
Yutaka Matsuda et al.
CHEMISTRYSELECT (2020)
Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody-Drug Conjugates Produced by AJICAP First Generation Technology
Yutaka Matsuda et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2020)
Perspectives from nearly five decades of total synthesis of natural products and their analogues for biology and medicine
K. C. Nicolaou et al.
NATURAL PRODUCT REPORTS (2020)
A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation
Yutaka Matsuda et al.
ANTIBODIES (2020)
Antibody Conjugates-Recent Advances and Future Innovations
Donmienne Leung et al.
ANTIBODIES (2020)
AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies
Kei Yamada et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
The Role of Organic Synthesis in the Emergence and Development of Antibody-Drug Conjugates as Targeted Cancer Therapies
K. C. Nicolaou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Antibody-drug conjugates- stability and formulation
Corinna Duerr et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP
Yutaka Matsuda et al.
ANALYTICAL CHEMISTRY (2019)
Good Manufacturing Practice Strategy for Antibody-Drug Conjugate Synthesis Using Site-Specific Chemical Conjugation: First-Generation AJICAP
Yutaka Matsuda et al.
ACS OMEGA (2019)
Hydrophilic interaction chromatography for the analysis of biopharmaceutical drugs and therapeutic peptides: A review based on the separation characteristics of the hydrophilic interaction chromatography phases
Tohru Ikegami
JOURNAL OF SEPARATION SCIENCE (2019)
Gram-Scale Antibody-Drug Conjugate Synthesis by Site-Specific Chemical Conjugation: AJICAP First Generation
Yutaka Matsuda et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)
Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody-drug conjugation
Kanwen Yang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Kyoji Tsuchikama et al.
PROTEIN & CELL (2018)
Protein purification using solid-phase extraction on temperature-responsive hydrogel-modified silica beads
Kohei Okubo et al.
JOURNAL OF CHROMATOGRAPHY A (2018)
Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry
Valentina D'Atri et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Fate of Antibody-Drug Conjugates in Cancer Cells
Cecile Chalouni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Automated On-tip Affinity Capture Coupled with Mass Spectrometry to Characterize Intact Antibody-Drug Conjugates from Blood
Ke Sherry Li et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2018)
Challenges and new frontiers in analytical characterization of antibody-drug conjugates
Anil Wagh et al.
MABS (2018)
Process Development and Structural Characterization of an Anti-Notch 3 Antibody-Drug Conjugate
Durgesh V. Nadkarni et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2018)
An overview of the total synthesis of africane-type sesquiterpenoids
Yutaka Matsuda et al.
TETRAHEDRON LETTERS (2018)
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
Masato Kiyoshi et al.
SCIENTIFIC REPORTS (2018)
Bioprocess development of antibody-drug conjugate production for cancer treatment
Jianfa Ou et al.
PLOS ONE (2018)
Evaluation of size exclusion chromatography columns packed with sub-3 μm particles for the analysis of biopharmaceutical proteins
Alexandre Goyon et al.
JOURNAL OF CHROMATOGRAPHY A (2017)
Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates
Mary Jane Masson Hinrichs et al.
CLINICAL CANCER RESEARCH (2017)
Navigating the Chiral Pool in the Total Synthesis of Complex Terpene Natural Products
Zachary G. Brill et al.
CHEMICAL REVIEWS (2017)
Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes
Murli Krishna et al.
FRONTIERS IN IMMUNOLOGY (2016)
Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates
Magdalena Dorywalska et al.
BIOCONJUGATE CHEMISTRY (2015)
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
William R. Strohl
BIODRUGS (2015)
Transient conformational modification of immunoglobulin G during purification by protein A affinity chromatography
Pete Gagnon et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
Penny Bryant et al.
MOLECULAR PHARMACEUTICS (2015)
Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
George Badescu et al.
BIOCONJUGATE CHEMISTRY (2014)
Immunogenicity of therapeutic proteins: Influence of aggregation
Kirsty D. Ratanji et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Site-specific antibody drug conjugates for cancer therapy
Siler Panowski et al.
MABS (2014)
Methods for site-specific drug conjugation to antibodies
Christopher R. Behrens et al.
MABS (2014)
Divergent strategy in natural product total synthesis
Jun Shimokawa
TETRAHEDRON LETTERS (2014)
Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
Pavel Strop et al.
CHEMISTRY & BIOLOGY (2013)
Purification of monoclonal antibodies by hydrophobic interaction chromatography under no-salt conditions
Sanchayita Ghose et al.
MABS (2013)
Native Intact Mass Determination of Antibodies Conjugated with Monomethyl Auristatin E and F at Interchain Cysteine Residues
John F. Valliere-Douglass et al.
ANALYTICAL CHEMISTRY (2012)
Highly Aggregated Antibody Therapeutics Can Enhance the in Vitro Innate and Late-stage T-cell Immune Responses
Marisa K. Joubert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Engineered Synthetic Polymer Nanoparticles as IgG Affinity Ligands
Shih-Hui Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Marketed therapeutic antibodies compendium
Janice M. Reichert
MABS (2012)
Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
Stephen I. Rudnick et al.
CANCER RESEARCH (2011)
Analytical methods for physicochemical characterization of antibody drug conjugates
Aditya Wakankar et al.
MABS (2011)
Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Jagath R. Junutula et al.
CLINICAL CANCER RESEARCH (2010)
Recovery and purification process development for monoclonal antibody production
Hui F. Liu et al.
MABS (2010)
Monoclonal antibody purification with hydroxyapatite
Pete Gagnon
NEW BIOTECHNOLOGY (2009)
Host Cell Protein Clearance During Protein A Chromatography: Development of an Improved Column Wash Step
Abhinav A. Shukla et al.
BIOTECHNOLOGY PROGRESS (2008)
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
KJ Hamblett et al.
CLINICAL CANCER RESEARCH (2004)
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity
JA Francisco et al.
BLOOD (2003)